These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 28956284)

  • 1. Diagnosing filamentous fungal infections in immunocompromised patients applying computed tomography-guided percutaneous lung biopsies: a 12-year experience.
    Lass-Flörl C; Aigner M; Nachbaur D; Eschertzhuber S; Bucher B; Geltner C; Bellmann R; Lackner M; Orth-Höller D; Würzner R; Weiss G; Glodny B
    Infection; 2017 Dec; 45(6):867-875. PubMed ID: 28956284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of percutaneous lung biopsy for diagnosing filamentous fungal infections in hematologic malignancies.
    Nosari A; Anghilieri M; Carrafiello G; Guffanti C; Marbello L; Montillo M; Muti G; Ribera S; Vanzulli A; Nichelatti M; Morra E
    Haematologica; 2003 Dec; 88(12):1405-9. PubMed ID: 14687995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients.
    Lass-Flörl C; Resch G; Nachbaur D; Mayr A; Gastl G; Auberger J; Bialek R; Freund MC
    Clin Infect Dis; 2007 Oct; 45(7):e101-4. PubMed ID: 17806041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of computed tomography (CT) and of fine needle aspiration biopsy (FNAB) in early diagnosis of fungal pulmonary infections. Study of infections from filamentous fungi in haematologically immunodeficient patients.
    Carrafiello G; Laganà D; Nosari AM; Guffanti C; Morra E; Recaldini C; D'Alba MJ; Sonvico U; Vanzulli A; Fugazzola C
    Radiol Med; 2006 Feb; 111(1):33-41. PubMed ID: 16623303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients.
    El-Mahallawy HA; Shaker HH; Ali Helmy H; Mostafa T; Razak Abo-Sedah A
    Med Mycol; 2006 Dec; 44(8):733-9. PubMed ID: 17127630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomography guided percutaneous lung biopsies and suspected fungal infections in pediatric cancer patients.
    Kropshofer G; Kneer A; Edlinger M; Meister B; Salvador C; Lass-Flörl C; Freund M; Crazzolara R
    Pediatr Blood Cancer; 2014 Sep; 61(9):1620-4. PubMed ID: 24803392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of open lung biopsy in the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies.
    Kim K; Lee MH; Kim J; Lee KS; Kim SM; Jung MP; Han J; Sung KW; Kim WS; Jung CW; Yoon SS; Im YH; Kang WK; Park K; Park CH
    Am J Hematol; 2002 Oct; 71(2):75-9. PubMed ID: 12353303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspergillus PCR-based investigation of fresh tissue and effusion samples in patients with suspected invasive Aspergillosis enhances diagnostic capabilities.
    Reinwald M; Spiess B; Heinz WJ; Heussel CP; Bertz H; Cornely OA; Hahn J; Lehrnbecher T; Kiehl M; Laws HJ; Wolf HH; Schwerdtfeger R; Schultheis B; Burchardt A; Klein M; Dürken M; Claus B; Schlegel F; Hummel M; Hofmann WK; Buchheidt D
    J Clin Microbiol; 2013 Dec; 51(12):4178-85. PubMed ID: 24108612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
    Musher B; Fredricks D; Leisenring W; Balajee SA; Smith C; Marr KA
    J Clin Microbiol; 2004 Dec; 42(12):5517-22. PubMed ID: 15583275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results.
    Buchheidt D; Baust C; Skladny H; Ritter J; Suedhoff T; Baldus M; Seifarth W; Leib-Moesch C; Hehlmann R
    Clin Infect Dis; 2001 Aug; 33(4):428-35. PubMed ID: 11462176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between PCR and detection of antigen in sera for diagnosis of pulmonary aspergillosis.
    Kawamura S; Maesaki S; Noda T; Hirakata Y; Tomono K; Tashiro T; Kohno S
    J Clin Microbiol; 1999 Jan; 37(1):218-20. PubMed ID: 9854096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and outcome of CT-guided lung biopsy in patients with hematological diseases and suspected fungal pneumonia.
    Sharma SK; Kumar S; Singh AK; Seth T; Mishra P; Mahapatra M; Sharma S; Tyagi S; Xess I; Ray R
    J Infect Dev Ctries; 2013 Oct; 7(10):748-52. PubMed ID: 24129628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
    Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
    Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA-microarray from primary clinical samples.
    Boch T; Reinwald M; Postina P; Cornely OA; Vehreschild JJ; Heußel CP; Heinz WJ; Hoenigl M; Eigl S; Lehrnbecher T; Hahn J; Claus B; Lauten M; Egerer G; Müller MC; Will S; Merker N; Hofmann WK; Buchheidt D; Spiess B
    Mycoses; 2015 Dec; 58(12):735-45. PubMed ID: 26497302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive aspergillosis in the immunocompromised host: utility of computed tomography and bronchoalveolar lavage.
    Brown MJ; Worthy SA; Flint JD; Müller NL
    Clin Radiol; 1998 Apr; 53(4):255-7. PubMed ID: 9585039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
    Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
    Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive pulmonary aspergillosis with spontaneous resolution and the diagnostic utility of PCR from tissue specimens.
    Hope WW; Padwell A; Guiver M; Denning DW
    J Infect; 2004 Aug; 49(2):136-40. PubMed ID: 15236920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary invasive aspergillosis and candidiasis in immunocompromised patients: a comparative study of the high-resolution CT findings.
    Althoff Souza C; Müller NL; Marchiori E; Escuissato DL; Franquet T
    J Thorac Imaging; 2006 Aug; 21(3):184-9. PubMed ID: 16915062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of CT features of Aspergillus and bacterial pneumonia in severely neutropenic patients.
    Bruno C; Minniti S; Vassanelli A; Pozzi-Mucelli R
    J Thorac Imaging; 2007 May; 22(2):160-5. PubMed ID: 17527120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of Aspergillus-PCR for detection of invasive aspergillosis in immunosuppressed patients.
    Lass-Flörl C; Gunsilius E; Gastl G; Freund M; Dierich MP; Petzer A
    Mycoses; 2005; 48 Suppl 1():12-7. PubMed ID: 15826281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.